Nasal polyps are common, affecting up to 4% of the general population, and can affect quality of life, but are usually benign. However, a new study suggests that when they occur in older patients (≥ ...

Constantly congested? The culprit could be nasal polyps, noncancerous growths that leave your nose stuffed and your sense of smell stymied. We asked a top ear, nose and throat specialist to tell us ...

Nasal polyps are noncancerous soft tissue growths that form in your nasal passages and sinuses. They’re often a result of inflammation from sinusitis, allergens, or other issues. Experts don’t know ...

You may need to remove nasal polyps if they’re large enough to interfere with your quality of life. Surgery, called nasal polypectomy, is the standard procedure used. Nasal polyps refer to small ...

Chronic rhinosinusitis (CRS) is a highly prevalent and debilitating inflammatory condition that affects the sinuses and nasal cavity, impacting approximately 1 in 8 people globally. 1,2 It is ...

– The Phase III POLYP 1 and POLYP 2 studies of Xolair in adults with chronic rhinosinusitis with nasal polyps (CRSwNP) with inadequate response to intranasal corticosteroids met both co-primary ...

Please provide your email address to receive an email when new articles are posted on . In fact, many patients may self-medicate with over-the-counter allergy medications for months or years without ...

THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the ...

A search of the peer-reviewed literature turned up inconsistent findings on the effectiveness of corticosteroid irrigation for the treatment of chronic rhinosinusitis (CRS) with nasal polyps. The ...

Reduced health-related quality of life was identified in patients with chronic rhinosinusitis with nasal polyps compared with the general population—regardless of previous sinus surgery or presence of ...

The FDA expanded the approval of fluticasone propionate (Xhance) nasal spray for chronic rhinosinusitis to also include treatment of adults without nasal polyps, manufacturer Optinose announced on ...